Abstract:Introduction: Visualization of tumor angiogenesis using radionuclide targeting provides important diagnostic information. In previous study, we proved that an arginine-arginine-leucine (RRL) peptide should be a tumor endothelial cell specific binding sequence. The overall aim of this study was to evaluate whether Tc-99m-radiolabeled RRL could be noninvasively used for imaging of malignant tumors in vivo, and act as a new molecular probe targeting tumor angiogenesis.Methods: The RRL peptide was designed and radiosynthesized with Tc-99m by a one-step method. The radiolabeling efficiency and radiochemical purity were then characterized in vitro. Tc-99m-RRL was injected intravenously in HepG2 xenograft-bearing BALB/c nude mice. Biodistribution and in vivo imaging were performed periodically. The relationship between tumor size and %ID uptake of Tc-99m-RRL was also explored.Results: The labeling efficiencies of Tc-99m-RRL reached 76.9%+/- 64.5% (n = 6) within 30-60 min at room temperature, and the radiochemical purity exceeded 96% after purification. In vitro stability experiment revealed the radiolabeled peptide was stable. Biodistribution data showed that Tc-99m-RRL rapidly cleared from the blood and predominantly accumulated in the kidneys and tumor. The specific uptake of Tc-99m-RRL in tumor was significantly higher than that of unlabeled RRL blocking and free pertechnetate control test after injection (p<0.05). The ratio of the tumor-to-muscle exceeded 6.5, tumor-to-liver reached 1.98 and tumor-to-blood reached 1.95. In planar gamma imaging study, the tumors were imaged clearly at 2-6 h after injection of Tc-99m-RRL, whereas the tumor was not imaged clearly in blocking group. The tumor-to-muscle ratio of images with Tc-99m-RRL was comparable with that of F-18-FDG PET images. Immunohistochemical analysis verified the excessive vasculature of tumor. There was a linear relationship between the tumor size and uptake of Tc-99m-RRL with R-2 = 0.821.Conclusion: Tc-99m-RRL can be used as a potential candidate for visualization of tumor angiogenesis in malignant carcinomas.

Identification of a Novel Vascular Endothelial Growth Factor Receptor-3-Targeting Peptide for Molecular Imaging of Metastatic Lymph Nodes

Identification of a VEGFR-3 binding peptide TMVP1 for enhancing drug delivery efficiency and therapeutic efficacy against tumor lymphangiogensis

A TMVP1-modified near-infrared nanoprobe: molecular imaging for tumor metastasis in sentinel lymph node and targeted enhanced photothermal therapy

Molecular Imaging of Tumor Angiogenesis Using Rgd-Labeled Iron Oxide Nanoparticles

PET Imaging of VEGFR with a Novel 64Cu-Labeled Peptide.

Homodimeric Peptide Radiotracer [68Ga]ga-Nota-(tmvp1)2 for VEGFR-3 Imaging of Cervical Cancer Patients.

Assessment of a Novel VEGF Targeted Agent Using Patient-Derived Tumor Tissue Xenograft Models of Colon Carcinoma with Lymphatic and Hepatic Metastases

Identification Of A Novel Peptide Ligand Of Human Vascular Endothelia Growth Factor Receptor 3 For Targeted Tumor Diagnosis And Therapy

Synthesis, Radiolabeling, and Biodistribution Study of a Novel DOTA-Peptide for Targeting Vascular Endothelial Growth Factor Receptors in the Molecular Imaging of Breast Cancer

Primary Preclinical and Clinical Evaluation of 68Ga-Dota-tmvp1 As a Novel VEGFR-3 PET Imaging Radiotracer in Gynecological Cancer

Evaluation of Tumor Vascular Targeting Agents Labelled with 131I in Imaging of Tumor

Dual Integrin Αvβ 3 and NRP-1-Targeting Paramagnetic Liposome for Tumor Early Detection in Magnetic Resonance Imaging

A Novel Tc-99m-Labeled Molecular Probe For Tumor Angiogenesis Imaging In Hepatoma Xenografts Model: A Pilot Study

Identification of a novel peptide ligand of human vascular endothelia growth factor receptor 3 for targeted tumour diagnosis and therapy.

Pet Imaging of Tumor Metastasis Using 68Ga-Labeled A Novel Tumor-Homing Peptide Tmtp1

A novel near-infrared EGFR targeting probe for metastatic lymph node imaging in preclinical mouse models

18F Labeled RGD‐A7R Peptide for Dual Integrin and VEGF‐targeted Tumor Imaging in Mice Bearing U87MG Tumors

Positron Emission Tomography Imaging of Vascular Endothelial Growth Factor Receptor Expression with 61Cu-Labeled Lysine-Tagged VEGF121

Identification Of Vegfr2-Binding Peptides Using High Throughput Bacterial Display Methods And Functional Assessment

Dual Targeting of Integrin αvβ3 and VEGF Receptor Improves PET Imaging of Breast Cancer

18 F-radiolabeled Analogs of Peptide RGD-A7R for Simultaneous PET Imaging of Both Αvβ3 and VEGF in Tumors